June 6, 2013, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck, was named a finalist in the New Product of the Year category of the 2013 American Business Awards for two products introduced this past year: the Muse™ Cell Analyzer and the Direct Detect® Protein Quantitation System. The awards are given as a national recognition to new products that have impacted their industries in significant ways.
"Our goal is to always help our customers perform better scientific research and make progress towards the treatment, cure, and prevention of major diseases. Both Muse™ and Direct Detect® products are faster and easier to use than their traditional counterparts in these efforts, reducing workflow and complexity," said John Sweeney, Head of Merck Millipore’s Bioscience Business Unit. "We are very proud to have these products recognized by the prestigious American Business Awards this year."
The Muse™ Cell Analyzer provides greater accuracy and precision than manual hemocytometry or image-based automated analysis. Through real-time, multi-dimensional information on cell populations, the Muse™ Cell Analyzer enables faster, more accurate decision-making, more productive workflows and greater insight in to cell health. Muse™ Cell Analyzer has allowed Merck Millipore’s customers to run more samples in less time with greater accuracy.
The Direct Detect® system for rapid, simplified protein quantitation taps into Merck Millipore’s membrane expertise to enable infrared-based measurement of amide bonds in protein chains, an intrinsic component of every protein, without relying on amino acid composition, dye-binding properties or redox potential. The Direct Detect® system enables researchers to improve the speed and accuracy of their quantitation, a necessary component of most downstream applications.
More than 3,000 nominations from organizations of all sizes and virtually every industry were submitted to The American Business Awards for consideration in a wide range of categories, including Most Innovative Company of the Year, Management Team of the Year, Best New Product or Service of the Year, and Executive of the Year. Roughly 35% of submissions were named finalists by a panel of more than 140 executives over five weeks of judging. Merck Millipore’s Muse™ and Direct Detect® products are both finalists in the New Product of the Year category for Health and Pharmaceutical Products, and will ultimately receive either a Gold, Silver or Bronze “Stevie” Award in a ceremony to be held in San Francisco on September 16.
Details about The American Business Awards and the list of Finalists in all categories are available at www.stevieawards.com/aba
About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6 billion Merck Millipore operates as EMD Millipore in the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
About the Stevie® Awards
Stevie® Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie® Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevie® Awards recognize outstanding performances in the workplace worldwide. Learn more about The Stevie® Awards at www.stevieawards.com.